Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Queensland Health
Deloitte
Moodys
Julphar
Healthtrust
Medtronic
Fish and Richardson
Chubb

Generated: September 19, 2018

DrugPatentWatch Database Preview

CETROTIDE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Cetrotide, and what generic alternatives are available?

Cetrotide is a drug marketed by Emd Serono Inc and is included in one NDA. There is one patent protecting this drug.

The generic ingredient in CETROTIDE is cetrorelix. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the cetrorelix profile page.

Drug patent expirations by year for CETROTIDE
Generic Entry Opportunity Date for CETROTIDE
Generic Entry Date for CETROTIDE*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
INJECTABLE;INJECTION

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Synonyms for CETROTIDE
(S)-1-(((R)-2-((S)-2-((S)-2-((R)-2-((R)-2-((R)-2-acetamido-3-(naphthalen-2-yl)propanamido)-3-(4-chlorophenyl)propanamido)-3-(pyridin-3-yl)propanamido)-3-hydroxypropanamido)-3-(4-hyd
120287-85-6
130143-01-0
287C856
ABP000574
Ac-(D-Ala[3-(2-Naphthyl)])-[D-Phe(4-Cl)]-(D-Ala[3-(3-Pyridyl)])-Ser-Tyr-(D-Cit)-Leu-Arg-Pro-D-Ala-Oh
AC-28734
Ac-D-Nal(2)-D-Phe(pCl)-D-Pal(3)-Ser-Tyr-D-Cit-Leu-Arg-Pro-D-Ala-NH2
AKOS015994648
AM000626
BDBM50369965
C-35500
C70H92ClN17O14
Cetrelix Acetate
Cetrorelix
Cetrorelix (INN)
Cetrorelix [INN:BAN]
Cetrorelix acetate
Cetrorelix Acetate(Cetrotide)/
Cetrorelix(Cetrorelix acetate)
Cetrorelixum
Cetrorelixum [INN-Latin]
Cetrotide (TN)
CHEBI:59224
CHEMBL1200490
D07665
D09OLZ
DB00050
DTXSID7040996
FT-0647968
FT-0656251
GTPL1190
HS-2008
HSDB 7696
KS-00002WUP
MolPort-009-194-176
MolPort-042-652-596
N-acetyl-3-(2-naphthyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridyl)-D-alanyl-L-seryl-L-tyrosyl-N5-carbomoyl-D-ornithyl-L-leucyl-L-prolyl-D-alaninamide
N-Acetyl-3-(2-naphthyl)-D-alanyl-p-chloro-D-phenylalanyl-3-(3-pyridyl)-D-alanyl-L-seryl-L-tyrosyl-N(sup 5)-carbamoyl-D-ornithyl-L-leucyl-L-arginyl-L-prolyl-D-alaninamide
N-acetyl-3-(naphthalen-2-yl)-D-alanyl-4-chloro-D-phenylalanyl-3-(pyridin-3-yl)-D-alanyl-L-seryl-L-tyrosyl-N(5)-carbamoyl-D-ornithyl-L-leucyl-L-arginyl-L-prolyl-D-alaninamide
OON1HFZ4BA
roxyphenyl)propanamido)-5-ureidopentanoyl)-L-leucyl-L-arginyl)-N-((R)-1-amino-1-oxopropan-2-yl)pyrrolidine-2-carboxamide
SB 75
SB-075
SC-50568
SC-82639
SCHEMBL19712202
SCHEMBL61331
UNII-OON1HFZ4BA
V0412
Y-100040

US Patents and Regulatory Information for CETROTIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Emd Serono Inc CETROTIDE cetrorelix INJECTABLE;INJECTION 021197-001 Aug 11, 2000 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Emd Serono Inc CETROTIDE cetrorelix INJECTABLE;INJECTION 021197-002 Aug 11, 2000 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for CETROTIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Emd Serono Inc CETROTIDE cetrorelix INJECTABLE;INJECTION 021197-001 Aug 11, 2000 ➤ Sign Up ➤ Sign Up
Emd Serono Inc CETROTIDE cetrorelix INJECTABLE;INJECTION 021197-002 Aug 11, 2000 ➤ Sign Up ➤ Sign Up
Emd Serono Inc CETROTIDE cetrorelix INJECTABLE;INJECTION 021197-001 Aug 11, 2000 ➤ Sign Up ➤ Sign Up
Emd Serono Inc CETROTIDE cetrorelix INJECTABLE;INJECTION 021197-001 Aug 11, 2000 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Supplementary Protection Certificates for CETROTIDE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
9C0031 Belgium ➤ Sign Up PRODUCT NAME: ACETATE DE CETRORELIX; REGISTRATION NO/DATE: EU/1/99/100/001 19990413
90029 Netherlands ➤ Sign Up PRODUCT NAME: CETRORELIX, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAAR DBAAR ZUUR ADDITIEZOUT, IN HET BIJZONDER CETRORELIX ACETAAT; REGISTRATION NO/DATE: EU/1/99/100/001-003 19990413
/1999 Austria ➤ Sign Up PRODUCT NAME: CETRORELIX UND PHARMAZEUTISCH ANNEHMBARE SAEUREADDITIONSSALZE DAVON, INSBESONDERE CETRORELIXACETAT; REGISTRATION NO/DATE: EU/1/99/100/001- EU/1/99/100/003 19990413
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Queensland Health
Deloitte
Moodys
Julphar
Healthtrust
Medtronic
Fish and Richardson
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.